Sign in
4

Changes in Ownership

Imunon, Inc. Filed Acc 0001437749-22-015057

Options or other derivatives

  • Chairman, President and CEO acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tardugno Michael H Chairman, President and CEO 2022-06-13 Grant or award · Option to Purchase Celsion Common Stock +90,000 303,068 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…